Sexual Dysfunctions, Psychological News - LARVOL Sigma

Sexual Dysfunctions, Psychological

Welcome, Profile Billing Logout

26 Mechanisms of Action

|||||||||| Enrollment open: Postpartum Dyspareunia Resulting From Vaginal Atrophy (clinicaltrials.gov) - Apr 25, 2012
P=N/A, N=100, Recruiting, Sponsor: Meir Medical Center
Not yet recruiting --> Recruiting

|||||||||| Enrollment closed, Surgery: Dilators for Dyspareunia Prevention (clinicaltrials.gov) - Apr 12, 2012
P4, N=54, Active, not recruiting, Sponsor: Medstar Research Institute
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting

|||||||||| Trial termination: IMPASSE: Incidence of Male Pudendal Artery Stenosis in Suboptimal Erections Study (clinicaltrials.gov) - Apr 3, 2012
P=N/A, N=19, Terminated, Sponsor: Medtronic Endovascular
Recruiting --> Active, not recruiting Recruiting --> Terminated; Sufficient information gathered

|||||||||| Enrollment change: IMPASSE: Incidence of Male Pudendal Artery Stenosis in Suboptimal Erections Study (clinicaltrials.gov) - Apr 3, 2012
P=N/A, N=19, Terminated, Sponsor: Medtronic Endovascular
Recruiting --> Terminated; Sufficient information gathered N=350 --> 19

||||||||||  lidocaine topical / Generic mfg.
New P3 trial:  Therapy to Prevent Sexual Pain in Breast Cancer Survivors (clinicaltrials.gov) -  Feb 23, 2012
P3, N=50, Completed,  Sponsor: Oregon Health and Science University

|||||||||| Enrollment change: Patient Satisfaction and Complications With the New Titan (clinicaltrials.gov) - Feb 20, 2012
P=N/A, N=26, Completed, Sponsor: Copenhagen University Hospital at Herlev
N=350 --> 19 N=35 --> 26

|||||||||| Trial completion: Patient Satisfaction and Complications With the New Titan (clinicaltrials.gov) - Feb 20, 2012
P=N/A, N=26, Completed, Sponsor: Copenhagen University Hospital at Herlev
N=35 --> 26 Recruiting --> Completed

||||||||||  tadalafil / Generic mfg.
Enrollment closed:  Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapy (clinicaltrials.gov) -  Feb 18, 2012
P3, N=242, Active, not recruiting,  Sponsor: Radiation Therapy Oncology Group
Recruiting --> Completed Recruiting --> Active, not recruiting

||||||||||  tadalafil / Generic mfg.
Trial completion:  A Study in Erectile Dysfunction (clinicaltrials.gov) -  Feb 9, 2012
P4, N=623, Completed,  Sponsor: Eli Lilly and Company
Recruiting --> Active, not recruiting Active, not recruiting --> Completed

|||||||||| Trial completion: Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) (clinicaltrials.gov) - Feb 5, 2012
P3, N=626, Completed, Sponsor: BioSante Pharmaceuticals
Active, not recruiting --> Completed Recruiting --> Completed

|||||||||| Enrollment open: ECSIITED: Exploratory CSII Trial on Erectile Dysfunction in T2DM Patients (clinicaltrials.gov) - Jan 31, 2012
P4, N=20, Recruiting, Sponsor: Jothydev's Diabetes and Research Centre
Recruiting --> Completed Not yet recruiting --> Recruiting

|||||||||| Trial termination: Cognitive and Hormonal Treatment of Sex Offenders (clinicaltrials.gov) - Jan 29, 2012
P1, N=5, Terminated, Sponsor: Norwegian University of Science and Technology
Not yet recruiting --> Recruiting Recruiting --> Terminated; too few patients participated

|||||||||| Enrollment change: Cognitive and Hormonal Treatment of Sex Offenders (clinicaltrials.gov) - Jan 29, 2012
P1, N=5, Terminated, Sponsor: Norwegian University of Science and Technology
Recruiting --> Terminated; too few patients participated N=20 --> 5

||||||||||  sildenafil / Generic mfg.
New P1 trial:  Pharmacokinetics of Sildenafil Following Administration of an Chewable Tablet of Sildenafil Relative to Viagra (clinicaltrials.gov) -  Jan 17, 2012
P1, N=54, Completed,  Sponsor: Hanmi Pharmaceutical Company Limited

||||||||||  Priligy (dapoxetine) / AbbVie
Enrollment change:  COUPLE: Concomitant Use of PriLigy in Men Treated for Erectile Dysfunction (clinicaltrials.gov) -  Jan 11, 2012
P3, N=495, Completed,  Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
N=20 --> 5 N=656 --> 495

||||||||||  Priligy (dapoxetine) / AbbVie
Trial completion:  COUPLE: Concomitant Use of PriLigy in Men Treated for Erectile Dysfunction (clinicaltrials.gov) -  Jan 11, 2012
P3, N=495, Completed,  Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
N=656 --> 495 Recruiting --> Completed

||||||||||  vardenafil / Generic mfg., nifedipine extended release / Generic mfg.
Trial completion:  Vardenafil ODT (Orally Disintegrating Tablet) - Nifedipine Interaction Study (clinicaltrials.gov) -  Jan 4, 2012
P1, N=42, Completed,  Sponsor: Bayer
Recruiting --> Completed Recruiting --> Completed

|||||||||| Trial completion: BLOOM: Safety and Efficacy of LibiGel (clinicaltrials.gov) - Jan 3, 2012
P3, N=575, Completed, Sponsor: BioSante Pharmaceuticals
Recruiting --> Completed Active, not recruiting --> Completed

|||||||||| Trial completion: BLOOM: Safety and Efficacy of LibiGel (clinicaltrials.gov) - Jan 3, 2012
P3, N=597, Completed, Sponsor: BioSante Pharmaceuticals
Active, not recruiting --> Completed Active, not recruiting --> Completed

||||||||||  OPK 88004 / OPKO Health
Trial completion:  A Study of LY900010 in Erectile Dysfunction (clinicaltrials.gov) -  Dec 15, 2011
P2, N=378, Completed,  Sponsor: Eli Lilly and Company
Active, not recruiting --> Completed Active, not recruiting --> Completed

||||||||||  fluocinonide / Generic mfg.
Enrollment open:  Fluocinonide Cream in Treating Symptoms of Vaginal Dryness and Painful Sexual Intercourse In Patients With Breast Cancer Undergoing Hormone Therapy (clinicaltrials.gov) -  Dec 8, 2011
P2, N=31, Recruiting,  Sponsor: OHSU Knight Cancer Institute
Active, not recruiting --> Completed Active, not recruiting --> Recruiting

||||||||||  Zydena (udenafil) / Mezzion
Trial completion:  Effect of Udenafil on Spermatogenesis (clinicaltrials.gov) -  Nov 28, 2011
P1, N=239, Completed,  Sponsor: Warner Chilcott
Active, not recruiting --> Recruiting Active, not recruiting --> Completed

||||||||||  cyproterone acetate / Generic mfg.
Trial termination:  ANES: Androcur Non-interventional Study Among Patients With Carcinoma of the Prostate (clinicaltrials.gov) -  Nov 9, 2011
P=N/A, N=194, Terminated,  Sponsor: Bayer
Active, not recruiting --> Completed Recruiting --> Terminated

||||||||||  vardenafil / Generic mfg.
Enrollment change:  REPEAT - Real-Life Perception of Efficacy, Attitude, Satisfaction and Safety of Levitra Therapy (clinicaltrials.gov) -  Nov 8, 2011
P=N/A, N=7293, Completed,  Sponsor: Bayer
Recruiting --> Terminated N=891 --> 7293

||||||||||  Priligy (dapoxetine) / AbbVie
Trial completion:  The Asia-Pacific Flexible Dose Study of Dapoxetine and Patient Satisfaction in Premature Ejaculation Therapy (clinicaltrials.gov) -  Oct 16, 2011
P3, N=285, Completed,  Sponsor: Johnson & Johnson Pte Ltd
N=891 --> 7293 Recruiting --> Completed

|||||||||| Enrollment closed: SHAPE: Sexual Health on Antidepressants Through Physical Exercise (clinicaltrials.gov) - Oct 10, 2011
P=N/A, N=75, Active, not recruiting, Sponsor: University of Texas at Austin
Recruiting --> Completed Recruiting --> Active, not recruiting

|||||||||| New P3 trial: Trial of PED-1 in Male Patients With Premature Ejaculation (clinicaltrials.gov) - Sep 21, 2011
P3, N=159, Completed, Sponsor: Symyoo

|||||||||| Trial completion: LI-ESWT: The Effect of Low Intensity Shockwave Therapy for ED in Post Radical Prostatectomy Patients Who Didn't Respond to PDE5i (clinicaltrials.gov) - Sep 12, 2011
P3, N=20, Completed, Sponsor: Rambam Health Care Campus
Recruiting --> Active, not recruiting Recruiting --> Completed

||||||||||  sildenafil / Generic mfg.
New P2 trial:  Lybrido for Female Sexual Dysfunction (clinicaltrials.gov) -  Sep 11, 2011
P2, N=196, Completed,  Sponsor: Emotional Brain NY Inc.

||||||||||  tadalafil / Generic mfg.
New P2 trial:  Safety and Efficacy of YHD1023 in Erectile Dysfunction (clinicaltrials.gov) -  Aug 23, 2011
P2, N=104, Active, not recruiting,  Sponsor: Yuhan Corporation

||||||||||  fluocinonide / Generic mfg.
New P2 trial:  Fluocinonide Cream in Treating Symptoms of Vaginal Dryness and Painful Sexual Intercourse In Patients With Breast Cancer Undergoing Hormone Therapy (clinicaltrials.gov) -  Aug 22, 2011
P2, N=31, Recruiting,  Sponsor: OHSU Knight Cancer Institute

||||||||||  Priligy (dapoxetine) / AbbVie
New P1/2 trial:  Safety, Tolerability, Pharmacokinetics and Efficacy of YHD1044 (clinicaltrials.gov) -  Aug 16, 2011
P1/2, N=24, Completed,  Sponsor: Yuhan Corporation

||||||||||  Stendra (avanafil) / IEH Biopharma, Menarini, Endo
Enrollment change:  Research Evaluating an Investigational Medication for Erectile Dysfunction - Post-Prostatectomy (clinicaltrials.gov) -  Aug 11, 2011
P3, N=298, Completed,  Sponsor: VIVUS, Inc.
Recruiting --> Completed N=375 --> 298

||||||||||  Stendra (avanafil) / IEH Biopharma, Menarini, Endo
Enrollment change:  Long-Term Safety and Efficacy Study of Avanafil in Men With Erectile Dysfunction (clinicaltrials.gov) -  Aug 11, 2011
P3, N=712, Completed,  Sponsor: VIVUS, Inc.
N=375 --> 298 N=400 --> 712